October 12, 2025 a 09:31 am
Healthcare Stocks - Performance Analysis
Analyzing the current dynamics in the healthcare sector, we observe significant variability in stock performance over different time spans. The sector showcases both resilience and vulnerability, as companies navigate post-pandemic healthcare demands, regulatory influences, and market volatility. Through this performance analysis, we highlight key trends and potential investment insights from recent market data.
Healthcare Stocks Performance One Week 📊
Examining the one-week performance, it's evident that there is a mix of minor gains and notable losses. JNJ emerges as the lone stock with positive movement, whereas ISRG suffers the most significant decline, suggesting industry-specific challenges.
| Stock | Performance (%) | Performance |
|---|---|---|
| JNJ | 1.10% | |
| LLY | -0.72% | |
| ABBV | -1.44% | |
| ABT | -1.50% | |
| UNH | -1.51% | |
| TMO | -3.44% | |
| MRK | -3.62% | |
| AMGN | -2.62% | |
| ISRG | -5.08% |
Healthcare Stocks Performance One Month 📈
The one-month perspective reveals a distinct upward momentum in the sector, led by LLY and TMO achieving double-digit growth. Although ISRG continues to underperform, most stocks posted gains, indicating strong market fundamentals.
| Stock | Performance (%) | Performance |
|---|---|---|
| LLY | 10.48% | |
| TMO | 9.74% | |
| JNJ | 6.95% | |
| ABBV | 5.78% | |
| AMGN | 5.21% | |
| MRK | 4.38% | |
| UNH | 0.78% | |
| ABT | -0.79% | |
| ISRG | -4.33% |
Healthcare Stocks Performance Three Months 📉
Over the past three months, TMO leads the pack with a substantial gain, reinforced by strong market positioning. ISRG continues to struggle, marking significant underperformance, while other stocks exhibit moderate to strong growth, particularly in biotechnology, as represented by ABBV and UNH.
| Stock | Performance (%) | Performance |
|---|---|---|
| TMO | 22.82% | |
| JNJ | 19.97% | |
| ABBV | 19.26% | |
| UNH | 19.04% | |
| LLY | 6.87% | |
| MRK | 3.89% | |
| ABT | 1.12% | |
| AMGN | -1.56% | |
| ISRG | -17.58% |
Summary 💡
The healthcare sector shows mixed outcomes, with a broad spectrum of performance across timeframes. Notably, TMO and LLY are leading the upward trends, indicating strong market confidence and potential investment attractiveness. However, continuous underperformance by ISRG suggests a need for cautious reevaluation of its strategic position. Investors should consider diversifying their portfolios within the sector, focusing on emerging patterns and robust performers to capitalize on growth potential.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years